The natural growth history of persistent pulmonary subsolid nodules: Radiology, genetics, and clinical management
Authors:
Open Access
- 8 December 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 1011712
Abstract
The high detection rate of pulmonary subsolid nodules (SSN) is an increasingly crucial clinical issue due to the increased number of screening tests and the growing popularity of low-dose computed tomography (LDCT). The persistence of SSN strongly suggests the possibility of malignancy. Guidelines have been published over the past few years and guide the optimal management of SSNs, but many remain controversial and confusing for clinicians. Therefore, in-depth research on the natural growth history of persistent pulmonary SSN can help provide evidence-based medical recommendations for nodule management. In this review, we briefly describe the differential diagnosis, growth patterns and rates, genetic characteristics, and factors that influence the growth of persistent SSN. With the advancement of radiomics and artificial intelligence (AI) technology, individualized evaluation of SSN becomes possible. These technologies together with liquid biopsy, will promote the transformation of current diagnosis and follow-up strategies and provide significant progress in the precise management of subsolid nodules in the early stage of lung cancer.Keywords
This publication has 95 references indexed in Scilit:
- Lung Cancers Diagnosed at Annual CT Screening: Volume Doubling TimesRadiology, 2012
- Predicting sample size required for classification performanceBMC Medical Informatics and Decision Making, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Volume-Doubling Time of Pulmonary Nodules with Ground Glass Opacity at Multidetector CTAcademic Radiology, 2011
- Automated assessment of malignant degree of small peripheral adenocarcinomas using volumetric CT data: Correlation with pathologic prognostic factorsLung Cancer, 2010
- Pulmonary Ground-Glass Opacity (GGO) Lesions–Large Size and a History of Lung Cancer are Risk Factors for GrowthJournal of Thoracic Oncology, 2008
- Impact of Sample Size on the Performance of Multiple-Model Pharmacokinetic SimulationsAntimicrobial Agents and Chemotherapy, 2006
- Evolving Concepts in the Pathology and Computed Tomography Imaging of Lung Adenocarcinoma and Bronchioloalveolar CarcinomaJournal of Clinical Oncology, 2005
- Lung Cancer Screening with Low-Dose Helical CT in Korea: Experiences at the Samsung Medical CenterJournal of Korean Medical Science, 2005
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001